EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy

Amy S Paller iD, Joyce Teng, Juliette Mazereeuw-Hautier iD, Ángela Hernández-Martín iD, Céline Granier Tournier iD, Alain Hovnanian iD, Mandy Aldwin-Easton iD, Gianluca Tadini, Janice Schwartz iD, Eli Sprecher, Kiril Malovitski iD, Akemi Ishida-Yamamoto iD und 7 weitere

British Journal of Dermatology · 18.09.2025 · 193 (4) · 592-618

DOI: 10.1093/bjd/ljaf123 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Dermatology, online erschienen am 04.04.2025. Verfasst von Amy S Paller und 18 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine and the Ann and Robert H. Lurie Children's Hospital of…. Hauptthemen laut MEDLINE: Skin Diseases, Genetic, Ichthyosis. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the 2010 classification of ichthyoses, our understanding of hereditary epidermal differentiation disorders (EDDs) has markedly increased, allowing for consideration of new therapeutic targets based on disease pathogenesis. A new gene- and protein product function-based classification focuses on shared mechanisms of disease pathogenesis, with the possibility that grouped disorders may respond similarly to new therapeutics. These EDDs have been subdivided into syndromic (sEDD), nonsyndromic with features limited to skin and appendages, and predominantly palmoplantar skin involvement (nonsyndromic and syndromic). sEDDs have clinically important extracutaneous features related to the gene alteration. Often, recognition based on skin manifestations facilitates early gene-based diagnosis, discussion of prognosis, genetic counselling and the initiation of therapy. All sEDDs are rare; the most common are STS-sEDD (formerly known as X-linked ichthyosis) and SPINK5-sEDD (formerly known as Netherton syndrome). Given the rarity, frequent association with early demise and variable clinical features of sEDDs, the natural history of the diseases with advancing age and genotype–phenotype relationships are poorly defined. Of the 51 sEDDs, associated neurological (n = 36; 71%) and/or ophthalmological (n = 25; 49%) findings are most common, and 39% (n = 20) have associated hair abnormalities. The widespread use of topical lovastatin for cholesterol synthesis-related sEDDs represents the prototype of pathogenesis-based therapy. This concept of upstream inhibition to prevent metabolite accumulation and supplementation with the pathway end product potentially applies to other sEDDs, such as those affecting ceramide synthesis and transport. Topical or systemically administered inhibition of activated pathways is another potential approach, exemplified by the emerging treatment of SPINK5-sEDD with kallikrein inhibitors. Many sEDDs may be amenable to gene editing or the introduction of functional cDNA. However, even systemic treatments targeting cutaneous diseases may not address extracutaneous manifestations that arise during embryological development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin Diseases, GeneticIchthyosisHumansSyndromePhenotype

Autor:innen und Institutionen

  • Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine and the Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
  • Department of Dermatology, Medical University Innsbruck and Karl Landsteiner Institute for Paediatric Dermatology and Rare Diseases, Innsbruck, Austria.

ORCID-Profile: Amy S Paller, Juliette Mazereeuw-Hautier, Ángela Hernández-Martín, Céline Granier Tournier, Alain Hovnanian, Mandy Aldwin-Easton, Janice Schwartz, Kiril Malovitski, Akemi Ishida-Yamamoto, Keith Choate, Masashi Akiyama, Edel A O'Toole, Judith Fischer, Christine Bodemer, Antoni Gostynski, Matthias Schmuth

Zitieren

APA

Paller, A. S., Teng, J., Mazereeuw-Hautier, J., Hernández-Martín, Á., Granier Tournier, C., Hovnanian, A., Aldwin-Easton, M., Tadini, G., Schwartz, J., Sprecher, E., Malovitski, K., Ishida-Yamamoto, A., Choate, K., Akiyama, M., O'Toole, E. A., Fischer, J., Bodemer, C., Gostynski, A., & Schmuth, M. (2025). Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy. British Journal of Dermatology, 193(4), 592-618. https://doi.org/10.1093/bjd/ljaf123

Vancouver

Paller AS, Teng J, Mazereeuw-Hautier J, Hernández-Martín Á, Granier Tournier C, Hovnanian A, et al. Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy. British Journal of Dermatology. 2025;193(4):592-618. doi:10.1093/bjd/ljaf123

BibTeX
@article{Paller2025,
  author = {Paller, Amy S and Teng, Joyce and Mazereeuw-Hautier, Juliette and Hernández-Martín, Ángela and Granier Tournier, Céline and Hovnanian, Alain and Aldwin-Easton, Mandy and Tadini, Gianluca and Schwartz, Janice and Sprecher, Eli and Malovitski, Kiril and Ishida-Yamamoto, Akemi and Choate, Keith and Akiyama, Masashi and O'Toole, Edel A and Fischer, Judith and Bodemer, Christine and Gostynski, Antoni and Schmuth, Matthias},
  title = {Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy},
  journal = {British Journal of Dermatology},
  year = {2025},
  volume = {193},
  number = {4},
  pages = {592--618},
  doi = {10.1093/bjd/ljaf123}
}
Kostenlos starten →